BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37277708)

  • 1. Prognostic factors, oncological treatment and outcomes of uterine sarcoma: 10 years' clinical experience from a tertiary care center in Pakistan.
    Khan SR; Soomar SM; Asghari T; Ahmed A; Moosajee MS
    BMC Cancer; 2023 Jun; 23(1):510. PubMed ID: 37277708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1277-87. PubMed ID: 18506484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis.
    Huss A; Klar M; Hasanov MF; Juhasz-Böss I; Bossart M
    Arch Gynecol Obstet; 2023 Mar; 307(3):927-935. PubMed ID: 35780401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
    Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F
    Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
    Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
    Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade endometrial stromal sarcoma versus undifferentiated uterine sarcoma: a Turkish uterine sarcoma group study-001.
    Ayhan A; Tunc M; Boran N; Khatib G; Gokcu M; Simsek T; Ozen OI; Toptas T; Yalcin I; Meydanli MM
    Arch Gynecol Obstet; 2021 Aug; 304(2):475-483. PubMed ID: 33392719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial stromal sarcoma-A retropsective analysis of factors affecting recurrence.
    Agarwal R; Rajanbabu A; Nair IR; Satish C; Jose G; Unikrishnan UG
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():92-97. PubMed ID: 28738297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group.
    Kikuchi A; Yoshida H; Tsuda H; Nishio S; Suzuki S; Takehara K; Kino N; Sumi T; Kato K; Yokoyama M; Nakamura K; Takano M; Sato S; Kato H; Tamate M; Horie K; Kato T; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Yaegashi N; Satoh T
    Gynecol Oncol; 2023 Sep; 176():82-89. PubMed ID: 37478616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study.
    Wang F; Dai X; Chen H; Hu X; Wang Y
    BMC Cancer; 2022 Oct; 22(1):1050. PubMed ID: 36207687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.
    Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M;
    Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in undifferentiated uterine sarcoma: a subanalysis of the SARCUT study.
    Macuks R; Yildirim Y; Mancari R; Achimas-Cadariu P; Madhuri TK; Ortega E; Mallmann M; Zivanovic O; Zapardiel I;
    Arch Gynecol Obstet; 2023 Sep; 308(3):981-988. PubMed ID: 37193821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
    Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
    Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with uterine sarcoma: the SARCUT study.
    Zapardiel I; Gracia Segovia M; Macuks R; Mancari R; Achimas-Cadariu P; Corrado G; Bartusevicius A; Sukhin V; Muruzabal JC; Coronado Martín PJ; Gardella B; Piek JM; Concin N; Arab C; Papatheodorou D; Polterauer S; Iacoponi S; Nieto T; Lopez-Sanclemente MC; Trukhan H; Gil MM; Bakinovskaya I; Dalamanava A; Cucurull M; Rovski D; Baquedano L; Chiva L; Mardas M; Mavrichev SA; Klat J; Lopez de la Manzanara CA; Yildirim Y;
    Int J Gynecol Cancer; 2023 Jun; 33(6):897-904. PubMed ID: 37192761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma.
    Cabrera S; Bebia V; Acosta U; Franco-Camps S; Mañalich L; García-Jiménez A; Gil-Moreno A
    Clin Transl Oncol; 2021 Jun; 23(6):1210-1219. PubMed ID: 33210235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine sarcoma-current management and experience from a regional cancer centre in North India.
    Biswas A; Patel F; Kumar P; Srinivasan R; Bera A; Sharma SC; Rajwanshi A
    Arch Gynecol Obstet; 2013 Oct; 288(4):873-82. PubMed ID: 23580012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine sarcoma. Clinico-pathological characteristics and outcome.
    Sait HK; Anfinan NM; El Sayed ME; Alkhayyat SS; Ghanem AT; Abayazid RM; Sait KH
    Saudi Med J; 2014 Oct; 35(10):1215-22. PubMed ID: 25316466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
    Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
    Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.